-+ 0.00%
-+ 0.00%
-+ 0.00%

IN8BIO Expands Phase 1 INB-100 Gamma-Delta T Cell Therapy Trial to Ohio State University

Reuters·11/06/2025 21:14:36

Please log in to view news